Clinical trial
Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African…
NCT00145210 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00145210 |
|---|---|
| Title | Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans |
| Official title | A Double-Blind, Randomized, Placebo- and Active-Controlled, Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients With Hypertension |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Nebivolol and Atenolol |
| Enrollment | 630 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Mar 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: